NGNE Strangle Strategy
NGNE (Neurogene Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
NGNE (Neurogene Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $509.4M, a beta of 2.08 versus the broader market, a 52-week range of 14.65-37.266, average daily share volume of 183K, a public-listing history dating back to 2014, approximately 107 full-time employees. These structural characteristics shape how NGNE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.08 indicates NGNE has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a strangle on NGNE?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current NGNE snapshot
As of May 15, 2026, spot at $29.80, ATM IV 118.80%, IV rank 7.83%, expected move 34.06%. The strangle on NGNE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 245-day expiry.
Why this strangle structure on NGNE specifically: NGNE IV at 118.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a NGNE strangle, with a market-implied 1-standard-deviation move of approximately 34.06% (roughly $10.15 on the underlying). The 245-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NGNE expiries trade a higher absolute premium for lower per-day decay. Position sizing on NGNE should anchor to the underlying notional of $29.80 per share and to the trader's directional view on NGNE stock.
NGNE strangle setup
The NGNE strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NGNE near $29.80, the first option leg uses a $31.29 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NGNE chain at a 245-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NGNE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $31.29 | N/A |
| Buy 1 | Put | $28.31 | N/A |
NGNE strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
NGNE strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on NGNE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on NGNE
Strangles on NGNE are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the NGNE chain.
NGNE thesis for this strangle
The market-implied 1-standard-deviation range for NGNE extends from approximately $19.65 on the downside to $39.95 on the upside. A NGNE long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current NGNE IV rank near 7.83% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on NGNE at 118.80%. As a Healthcare name, NGNE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NGNE-specific events.
NGNE strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NGNE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NGNE alongside the broader basket even when NGNE-specific fundamentals are unchanged. Always rebuild the position from current NGNE chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on NGNE?
- A strangle on NGNE is the strangle strategy applied to NGNE (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With NGNE stock trading near $29.80, the strikes shown on this page are snapped to the nearest listed NGNE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are NGNE strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the NGNE strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 118.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a NGNE strangle?
- The breakeven for the NGNE strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current NGNE market-implied 1-standard-deviation expected move is approximately 34.06%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on NGNE?
- Strangles on NGNE are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the NGNE chain.
- How does current NGNE implied volatility affect this strangle?
- NGNE ATM IV is at 118.80% with IV rank near 7.83%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.